This inventor holds 1 USPTO granted patent. Top assignee: Zeneca Limited. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: The Innovations of Peter Grahame Ballard
Introduction
Peter Grahame Ballard is a notable inventor based in Stockport, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target endothelin receptors. His work has implications for treating various medical conditions associated with elevated levels of endothelin.
Latest Patents
Peter Grahame Ballard holds a patent for "N-heterocyclic sulfonamides having endothelin receptor activity." This invention concerns pharmaceutically useful compounds that possess endothelin receptor antagonist activity. The compounds are useful in treating diseases where elevated endothelin levels play a significant role. The patent also includes processes for manufacturing these novel compounds and their applications in medical treatment.
Career Highlights
Ballard is associated with Zeneca Limited, where he has contributed to innovative pharmaceutical research. His work has been instrumental in advancing the understanding of endothelin receptor activity and its therapeutic potential.
Collaborations
Some of his notable coworkers include Paul J Phillips and Robert Hugh Bradbury. Their collaboration has likely fostered an environment of innovation and research excellence.
Conclusion
Peter Grahame Ballard's contributions to pharmaceutical innovations highlight the importance of research in developing new treatments for medical conditions. His work continues to influence the field and offers hope for improved therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile